Search clinical trials for: partial responder

Total 2698 results

Pacific Health Foundation
Bristol-Myers Squibb

Completed

Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders (ADVPR)

Hepatitis B

United States
AbbVie (prior sponsor, Abbott)

Completed

A Study to Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults

Chronic Hepatitis C Infection
AbbVie

Completed

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

HCV | Hepatitis C Infection | Genotype 4
New York State Psychiatric Institute
Bristol-Myers Squibb; National Institute of Mental Health (NIMH); Otsuka Pharmaceutical...

Terminated

Treatment of Children With ADHD Who do Not Fully Respond to Stimulants (TREAT)

Attention Deficit Hyperactivity Disorder

United States
University of Sao Paulo

Unknown

Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients (ARIQUELI-ME)

Bipolar Disorder

Brazil
Novartis Pharmaceuticals

Completed

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis (GAIN)

Moderate to Severe Plaque-type Psoriasis

Germany
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults (MALACHITE II)

Chronic Hepatitis C Infection
Eli Lilly and Company

Completed

A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Major Depressive Disorder

United Kingdom, United States, Belgium, Austria, Australia, Germany, Sweden
Kaohsiung Medical University Chung-Ho Memorial...
National Taiwan University Hospital

Completed

Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy (BOLERO-CB)

Hepatitis C, Chronic

Taiwan
Vanderbilt University Medical Center
Janssen, LP

Withdrawn

Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment

Treatment Resistant Depression

United States
Pfizer

Completed

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Hepatitis, Chronic Active

United States
Korea University
Gilead Sciences

Completed

Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir (STEEP)

Chronic Hepatitis B

Korea, Republic of
Italfarmaco

Completed

Phase II Study With ITF2984 in Acromegalic Patients (POC)

Acromegaly

France, Hungary, Netherlands, Serbia, Czech Republic, Italy, Spain, Poland, Romania
Janssen R&D Ireland

Completed

TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy (ATTAIN)

Hepatitis C

United States, Australia, France, Poland, United Kingdom, Germany, Spain, Belgium, Israel, Portugal, Bulgaria, Romania, Denmark, Greece, Sweden, Canada, Czech Republic, Argentina, Brazil, Austria, Hungary, Switzerland, Puerto Rico, No...
Neuropsychiatric Research Institute, Fargo, North...

Withdrawn

Topiramate Augmentation in Bulimia Nervosa Partial Responders

Bulimia Nervosa

United States
Chronic Liver Disease Foundation
Merck Sharp & Dohme LLC; SCRI Development Innovations, LLC

Completed

Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy (OPTIMAL)

Chronic Hepatitis C | Genotype 1

United States
State University of New York - Upstate Medical...
Forest Laboratories

Completed

An 8 Week Open-Label Study to Evaluate the Efficacy and Safety of Acamprosate Calcium (Campral) as Augmentation Therapy in Patients With Anxiety Symptoms Who Are Only Partial Responders to SSRI or SNRI Antidepressants

Anxiety

United States
University of Chicago

Withdrawn

A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C

Hepatitis C | Hepatitis C Virus
GlaxoSmithKline

Completed

Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304

Epilepsy, Partial
Kadmon Corporation, LLC

Terminated

Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin (ENHANCE)

Hepatitis C

United States
Rambam Health Care Campus

Unknown

Efficacy & Safety of a 2nd Series of Low Intensity Shock Waves for ED on Partial Responders to First Treatment

Erectile Dysfunction

Israel
Centre for Addiction and Mental Health
Stanley Medical Research Institute

Completed

Tetrabenazine for Partial Responders

Schizophrenia | Schizoaffective Disorder

Canada
Pfizer

Terminated

Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease

Brazil, Germany, Korea, Republic of, Belgium, Spain, Slovakia, France
Novartis Pharmaceuticals

Completed

Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly

Acromegaly

Italy
AstraZeneca

Completed

Generalized Anxiety Disorder Adjunct Study

Anxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety States

United States
AstraZeneca
i3 Innovus

Completed

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France (REMAIN)

Gastroesophageal Reflux Disease

France
AstraZeneca
i3 Innovus

Completed

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US (REMAIN)

Gastroesophageal Reflux Disease (GERD)

United States
Fudan University

Recruiting

Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer

Advanced Breast Cancer | HR+/HER2- Breast Cancer

China
Menoufia University

Recruiting

Survival Rate of 2 Implant-supported Short-span Fixed Partial Dentures

Bone Loss | Implant Complication

Egypt
Biohaven Therapeutics Ltd.

Not yet recruiting

Long-term Safety and Tolerability of BHV-7000

Focal Epilepsy
Instituto do Cancer do Estado de São Paulo

Not yet recruiting

Study to Compare Two Partial Nephrectomy Techniques for Renal Tumors: Robot-assisted vs Videolaparoscopic (VPN x RANP)

Renal Cancer
Xuanwu Hospital, Beijing

Not yet recruiting

Subiculum Electrical Stimulation for Temporal Lobe Epilepsy With Biliteral Hippocampus Sclerosis(SESTB)

Epilepsy, Drug Resistant

China
University of Aarhus
Aarhus University Hospital; Aalborg University Hospital; Gødstrup Hospital; Regional...

Not yet recruiting

Blood Flow Restriction Exercise in Patients With an Achilles Tendon Rupture (BEAN)

Achilles Tendon Rupture
Karolinska University Hospital
University Hospital, Linkoeping

Recruiting

Responders and Non-responders in the Management of Heart Failure - Significance of Genetic Influence and Identification of Novel Informative Biomarkers (Responders)

Heart Failure | Pathophysiology

Sweden
Postgraduate Institute of Dental Sciences Rohtak

Not yet recruiting

Comparative Evaluation of Indirect vs. Direct Pulp Capping in Deep Carious Mandibular Molars

Indirect Pulp Capping | Reversible Pulpitis

India
Centrum Clinic IVF Center

Not yet recruiting

BEst Size for Ovulation Triggering in Poseidon 4 Patients (BEST 4 Study) (BEST)

Fertilization | Fertilization in Vitro
Postgraduate Institute of Dental Sciences Rohtak

Recruiting

Outcome Following Use of Different Concentrations of NaOCl as Wound Lavage and Hemostatic Agent in Partial Pulpotomy

Irreversible Pulpitis | Extremely Deep Caries | Partial Pulpotomy

India
Cairo University

Recruiting

Post Extraction Changes Following Ridge Preservation Using Partially Demineralized Dentin Block Versus Xenograft

Socket Preservation

Egypt
University Hospital, Basel, Switzerland

Not yet recruiting

Load Limits After Orthopaedic Surgery: Biofeedback vs. Conventional Method (AppPWB)

Surgery

Switzerland
Semmelweis University

Recruiting

Digital vs Conventional Impression in Capturing the Emergence Profile Around Maxillary Anterior Implant-supported Crowns

Dental Implants, Single-Tooth | Dental Impression Technique

Hungary
Neurona Therapeutics

Not yet recruiting

Effect of NRTX-1001, a Cellular Therapy Product, for the Treatment of Refractory Bilateral TLE

Epilepsy, Temporal Lobe
Menoufia University

Recruiting

Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors.

Renal Cell Carcinoma

Egypt
Menoufia University

Recruiting

Four-unit Implant Supported Fixed Partial Dentures Fabricated From Different Materials

Bone Loss | Prosthesis Survival

Egypt
Adiyaman University Research Hospital

Not yet recruiting

Hypobaric Spinal or Hyperbaric in Partial Hip Arthroplasty

Post Operative Pain

Turkey
Universitat Internacional de Catalunya

Recruiting

Dynamic Guided Implant Surgery VS Static Guided Surgery.

Partially Edentulous Patients | Bone Crest of at Least 10 mm Length and 6 mm Width | Patients of at Least 18 Years Old

Spain
Chiang Mai University

Recruiting

Study Compares Pneumothorax Recurrence: Absorbable Mesh vs. Pleurectomy in Primary Spontaneous Pneumothorax.

Primary Spontaneous Pneumothorax

Thailand
Tego Science, Inc.

Recruiting

A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear

Partial Thickness Rotator Cuff Tear

Korea, Republic of
EBG MedAustron GmbH
The Princess Margaret Cancer Foundation

Not yet recruiting

Radiotherapy Treatment Planning Comparison Using SBRT-PATHY (Photons) Versus CARBON-PATHY for Unresectable Bulky Tumors (S-C-PATHY)

Cancer

Austria
King's College London
Guy's and St Thomas' NHS Foundation Trust

Not yet recruiting

Outcome of Selective & Nonselective Caries Removal in Permanent Teeth (RCT-SNCR)

Deep Caries | Carious Exposure of Pulp
Rapport Therapeutics Inc.

Not yet recruiting

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Focal Onset Seizures

3

Subscribe